公开(公告)号：US11179369B2

公开(公告)日：2021-11-23

申请号：US16672296

申请日：2019-11-01

申请人： Wyeth, LLC

发明人： Eric Joel Benjamin ,  Wendy Ann Dulin ,  Yanning Lin ,  Kai Zhuang

IPC分类号： A61K31/407 ,  A61K9/20 ,  A61K9/28

摘要： The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.

公开(公告)号：US10463648B2

公开(公告)日：2019-11-05

申请号：US16058769

申请日：2018-08-08

申请人： Wyeth LLC

发明人： Eric Joel Benjamin ,  Wendy Ann Dulin ,  Yanning Lin ,  Kai Zhuang

IPC分类号： A61K31/407 ,  A61K9/20 ,  A61K9/28

摘要： The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.

公开(公告)号：US20230061743A1

公开(公告)日：2023-03-02

申请号：US17827560

申请日：2022-05-27

申请人： Wyeth LLC

发明人： Eric Joel Benjamin ,  Wendy Ann Dulin ,  Yanning Lin ,  Kai Zhuang

IPC分类号： A61K31/407 ,  A61K9/20 ,  A61K9/28

摘要： The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.